Pancreatic Cancer Research

ResearcherChinese Academy of SciencesActive in the last 2 years

Yi-Dan Zheng

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 9 November 2026

Matched on OpenAlex author ID A5086613826. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 2 papers · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. Design, synthesis and biological evaluation of novel ursolic acid derivatives as potent anti-pancreatic cancer agents. First author DOI 10.1016/j.bmc.2026.118607↗
  2. Obacunone potentiated PD-1 immunotherapy in pancreatic cancer by mediating CD36. Co-author DOI 10.1016/j.ejphar.2025.177367↗
  3. Pin1: Advances in pancreatic cancer therapeutic potential and inhibitors research. Co-author DOI 10.1016/j.bioorg.2024.107869↗
  4. Terpenoids from Nardostachys jatamansi and their cytotoxic activity against human pancreatic cancer cell lines. Co-author DOI 10.1016/j.phytochem.2022.113228↗
  5. A Carabrane-Type Sesquiterpenolide Carabrone from Carpesium cernuum Inhibits SW1990 Pancreatic Cancer Cells by Inducing Ferroptosis. Co-author DOI 10.3390/molecules27185841↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jun-Li Yang · 5 shared papers, 2022–2026 · strength 1.12
  2. Chun-Yan Sang · 4 shared papers, 2022–2025 · strength 0.87
  3. Nan Wang · 2 shared papers, 2024–2026 · strength 0.51
  4. Tharcisse Gatera · 1 shared paper, 2026 · strength 0.25
  5. Li-Mei Ma · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.